Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 24
1946 135
1947 144
1948 176
1949 148
1950 188
1951 161
1952 189
1953 169
1954 181
1955 176
1956 168
1957 207
1958 181
1959 192
1960 205
1961 194
1962 206
1963 226
1964 263
1965 241
1966 258
1967 247
1968 232
1969 265
1970 258
1971 279
1972 285
1973 253
1974 302
1975 282
1976 291
1977 297
1978 308
1979 309
1980 339
1981 379
1982 456
1983 481
1984 561
1985 541
1986 505
1987 549
1988 567
1989 508
1990 554
1991 667
1992 629
1993 625
1994 493
1995 441
1996 463
1997 279
1998 371
1999 515
2000 380
2001 353
2002 345
2003 406
2004 410
2005 434
2006 506
2007 459
2008 440
2009 344
2010 360
2011 326
2012 321
2013 372
2014 320
2015 357
2016 335
2017 317
2018 306
2019 271
2020 312
2021 275
2022 243
2023 248
2024 100

Text availability

Article attribute

Article type

Publication date

Search Results

25,261 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction.
Gaspardone C, Romagnolo D, Fasolino A, Falasconi G, Beneduce A, Fiore G, Didelon E, Fortunato F, Galdieri C, Posteraro GA, Ingallina G, Ancona F, Biondi F, Maio SD, Casiraghi A, Slavich M, Borio G, Savastano S, Leonardi S, Margonato A, Agricola E, Oppizzi M, Gaspardone A, Pappone C, Montorfano M. Gaspardone C, et al. Am Heart J. 2023 Jan;255:94-105. doi: 10.1016/j.ahj.2022.10.077. Epub 2022 Oct 20. Am Heart J. 2023. PMID: 36272451
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study.
Bhasin S, Lincoff AM, Basaria S, Bauer DC, Boden WE, Cunningham GR, Davey D, Dubcenco E, Fukumoto S, Garcia M, Granger CB, Kalahasti V, Khera M, Miller MG, Mitchell LM, O'Leary MP, Pencina KM, Snyder PJ, Thompson IM Jr, Travison TG, Wolski K, Nissen SE; TRAVERSE Study Investigators. Bhasin S, et al. Am Heart J. 2022 Mar;245:41-50. doi: 10.1016/j.ahj.2021.11.016. Epub 2021 Dec 4. Am Heart J. 2022. PMID: 34871580 Free article. Clinical Trial.
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Nicholls SJ, Bhatt DL, Buse JB, Prato SD, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, D'Alessio D; SURPASS-CVOT investigators. Nicholls SJ, et al. Am Heart J. 2024 Jan;267:1-11. doi: 10.1016/j.ahj.2023.09.007. Epub 2023 Sep 25. Am Heart J. 2024. PMID: 37758044 Free article. Clinical Trial.
OCEAN trial update.
Verma A, Wells G, Ha ACT, Kirchhof P, Hindricks G, Healey JS, Hill MD, Sharma M, Champagne J, Essebag V, Heidbuchel H, Sanders P, Birnie DH. Verma A, et al. Am Heart J. 2022 Jun;248:169. doi: 10.1016/j.ahj.2021.08.005. Epub 2021 Aug 19. Am Heart J. 2022. PMID: 34419415 No abstract available.
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
O'Neill WW, Anderson M, Burkhoff D, Grines CL, Kapur NK, Lansky AJ, Mannino S, McCabe JM, Alaswad K, Daggubati R, Wohns D, Meraj PM, Pinto DS, Popma JJ, Moses JW, Schreiber TL, Magnus Ohman E. O'Neill WW, et al. Am Heart J. 2022 Jun;248:139-149. doi: 10.1016/j.ahj.2022.02.006. Epub 2022 Feb 19. Am Heart J. 2022. PMID: 35192839 Free article. Clinical Trial.
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial.
Ahn JM, Kang DY, Lee PH, Ahn YK, Kim WJ, Nam CW, Jeong JO, Chae IH, Shiomi H, Kao PHL, Hahn JY, Her SH, Lee BK, Ahn TH, Chang K, Chae JK, Smyth D, Stone GW, Park DW, Park SJ; PREVENT Investigators. Ahn JM, et al. Am Heart J. 2023 Oct;264:83-96. doi: 10.1016/j.ahj.2023.05.017. Epub 2023 Jun 2. Am Heart J. 2023. PMID: 37271356 Clinical Trial.
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study.
Nishizaki Y, Miyauchi K, Iwata H, Inoue T, Hirayama A, Kimura K, Ozaki Y, Murohara T, Ueshima K, Kuwabara Y, Tanaka-Mizuno S, Yanagisawa N, Sato T, Daida H. Nishizaki Y, et al. Am Heart J. 2023 Mar;257:1-8. doi: 10.1016/j.ahj.2022.11.008. Epub 2022 Nov 11. Am Heart J. 2023. PMID: 36372250 Free article.
25,261 results
You have reached the last available page of results. Please see the User Guide for more information.